Pharmafile Logo

JPA Health

JPA Health is an award-winning public relations, marketing and advocacy firm known for sharing our clients’ commitment to making people healthier. With deep expertise in these core service categories, JPA offers a truly integrated model that delivers sustained business results.

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Avalere Health

Avalere Health is a leading global commercialization partner for the biopharmaceutical, medical technology, and wellness industries. Working from advisory to performance, we combine our knowledge and expertise across our disciplines…

View Profile

Cuttsy + Cuttsy

Here at Cuttsy+Cuttsy, we believe in making the world a better place by bringing trusted, accessible information to all and supporting understanding and outcomes across trials, treatments and beyond.

View Profile

Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.

View Profile

EatMoreFruit

Welcome to EatMoreFruit – a top 10 independent global healthcare communications agency based in the heart of London. Specialising in PR, digital, influencer & communication services, we deliver creative &…

View Profile

Four Agency Worldwide

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with content creators, PR gurus with advertising geniuses & sector specialists…

View Profile

Genetic Digital

We guide healthcare and life sciences organisations through digital transformation. Simplifying the complex world of tech and marketing, we create impactful assets and strategies to drive long-term growth and positive…

View Profile

Graphite Digital

We’re a digital CX agency collaborating with healthcare and pharmaceutical organisations to help them connect more deeply with their audiences through meaningful digital experiences. Our teams of specialists help clients…

View Profile

Havas Life London

We are a fully integrated agency that is 100% dedicated to creating standout communications in healthcare. Our success starts by strategically aligning promotion, medical education and PR across the product…

View Profile

Healthcare Research Worldwide

We are market research experts in the healthcare, pharmaceutical, device and diagnostics space, and have a wealth of experience in a wide range of therapy areas. Our scientifically grounded approaches…

View Profile

Impetus Digital

Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.

View Profile

MDNT

MDNT is a native Digital and Omnichannel agency focused solely on the healthcare, pharma, and life science industries. We’re highly experienced, no nonesense, and very good at what we do.

View Profile

Onyx Health

Onyx Health is a healthcare communications and PR agency based in the North East of England, but with a national and international reach. As we understand the healthcare market and…

View Profile

OPEN Health

OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.

View Profile

Resonant Group

Resonant Group is an award-winning group of agencies driven by the same core values and a common belief that lives can be transformed through better health communication.

View Profile

Sciterion

Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make a positive contribution to patient care. Real world experience of…

View Profile

Company Details

Euston House, 24 Eversholt Street, #106, London, NW1 1AD, United Kingdom
+44 (0) 20 388 406 57

 Latest Content from PMHub 

INmune Bio establishes global commercialization framework for Ebstrocel™ through strategic agreement with Uniphar

Press Releases | October 26, 2026 | Uniphar

Initial focus on named-patient access in selected European and MENA markets, providing a capital-efficient foundation for broader commercialization

Going private: what our year taught me about the patients pharma hasn’t yet spotted

A thought piece on the rise of private healthcare, and why brands should help new kinds of patients and HCPs

Redefining Pediatric Epilepsy Care: Why We Must Move Beyond Symptom Suppression

Press Releases | October 21, 2026 | Medscape Education

For families navigating pediatric epilepsy, the condition dictates every moment of their lives. The constant, crippling "anticipatory anxiety" of when the next seizure might hit transforms daily activities like grocery...

ANTHEM strengthens team with three appointments following Healthy Influence launch

Press Releases | October 19, 2026 | Resonant Group

Healthcare communications consultancy welcomes new talent as it invests in its next phase of growth

Access The Vector Issue 3: 15 payers describe the likely affect of EU General Pharmaceutical Legislation on orphan drug strategy

In the third issue of The Vector, Genesis Research asked 15 payers across France, Germany, Italy, Spain, and the UK how they believe the new EU General Pharmaceutical Legislation will...

Your AI pilot works. That’s the problem.

What breaks when you scale it won't be the model. It'll be your data.

“We’ve been told we can’t touch AI”

It's not been a great few weeks for anyone trying to make the calm, sensible case for AI tools. Researchers have been quitting the big labs, including Anthropic, and going...

What 90 Minutes of Live AI Case Practice Revealed About Physician Readiness

Press Releases | October 12, 2026 | Medscape Education

At EHA 2026 in Stockholm, 425 hematologists and oncologists attended an independent, 90-minute Medscape symposium on the practical and ethical use of AI. The format was case-based. The faculty presented...

On GLOBE Final Rule

The publication of the GLOBE Final Rule provides important clarity on the administration's approach to MFN pricing and what it could mean for pharmaceutical pricing, reimbursement, and access strategy globally....